This role is on-site in Fort Worth, Texas and would include: Lead development and execution of phase-appropriate, risk-based biological evaluation strategies for new and existing medical devices, combination products, components, materials, manufacturing changes, and product modifications. Critically evaluate complex or conflicting data, identify evidence gaps and product-safety risks, and recommend pragmatic, science-based paths forward that balance patient safety, regulatory expectations, program timing, and business needs.